Focal pulmonary masses in patients with rheumatological pathologies
DOI: 10.32364/2587-6821-2023-7-7-10
O.V. Teplyakova1,2, S.E. Shai1, Yu.V. Yakovleva1, I.V. Leshchenko1–3, A.V. Sarapulova1,2, O.V. Kolmakova2
1Ural State Medical University, Yekaterinburg, Russian Federation
2Novaya Bolnitsa LLC, Yekaterinburg, Russian Federation
2Ural Scientific Research Institute of Phtysiopulmonology — Branch of the National Medical Research Center of Phtysiopulmonology, Yekaterinburg, Russian Federation
Focal pulmonary masses in patients suffering from rheumatological diseases cause difficulties in conducting differential diagnosis with neoplastic and infectious processes, primarily with tuberculosis. In many cases, these masses are asymptomatic, being an accidental finding during routine examinations. Focal pulmonary masses can cause various comorbidities, such as hemoptysis and pneumothorax. In rheumatic diseases, the frequency of such masses ranges from 1 to 30%, as well as their incorrect diagnosis commonly leads to a wrong therapy choice. The article presents two clinical cases concerning the detection of focal pulmonary masses, which were observed during the visit to a rheumatologist: in patients with rheumatoid arthritis and with mixed connective tissue disease. Both cases are illustrated with follow-up computer tomography data. The presented clinical cases demonstrate various manifestations that a radiotherapist may encounter in this patient cohort: nodular masses, cavitation, infiltration, etc. Only a combination of clinical, anamnestic and laboratory data, along with X-ray data, allows to establish the correct diagnosis, commonly with case follow-up of the patient.
Keywords: focal pulmonary masses, rheumatoid arthritis, lung damage, rheumatoid nodules, tuberculosis, systemic connective tissue diseases.
For citation: Teplyakova O.V., Shai S.E., Yakovleva Yu.V., Leshchenko I.V., Sarapulova A.V., Kolmakova O.V. Focal pulmonary masses in patients with rheumatological pathologies. Russian Medical Inquiry. 2023;7(7):467–471 (in Russ.). DOI: 10.32364/2587-6821-2023-7-7-10.
About the authors:
Olga V. Teplyakova — Dr. Sc. (Med.), Professor of the Department of Outpatient Therapy, Ultrasound and Functional Diagnostics, Ural State Medical University; 3, Repin str., Yekaterinburg, 620028, Russian Federation; Head of the Center for Clinical Rheumatology, Novaya Bolnitsa LLC; 29, Zavodskaya str., Yekaterinburg, 620109, Russian Federation; ORCID iD 0000-0003-2114-0419.
Semyon E. Shai — 5th year student of the Ural State Medical University; 3, Repin str., Yekaterinburg, 620028, Russian Federation; ORCID iD 0009-0003-1199-6165.
Yulia V. Yakovleva — 5th year student of the Ural State Medical University; 3, Repin str., Yekaterinburg, 620028, Russian Federation; ORCID iD 0009-0004-8442-6793.
Igor V. Leshchenko — Dr. Sc. (Med.), Professor of the Department of Phthisiology and Pulmonology, Ural State Medical University; 3, Repin str., Yekaterinburg, 620028, Russian Federation; Research Director of the Novaya Bolnitsa LLC; 29, Zavodskaya str., Yekaterinburg, 620109, Russian Federation; Leading Researcher of the Ural Scientific Research Institute of Phtysiopulmonology — Branch of the National Medical Research Center of Phtysiopulmonology; 50, 22nd Partsiezd str., Yekaterinburg, 620039, Russian Federation; ORCID iD 0000-0002-1620-7159.
Anastasia V. Sarapulova — C. Sc. (Med.), Assistant of Outpatient Therapy, Ultrasound and Functional Diagnostics, Ural State Medical University; 3, Repin str., Yekaterinburg, 620028, Russian Federation; rheumatologist of the Center for Clinical Rheumatology, Novaya Bolnitsa LLC; 29, Zavodskaya str., Yekaterinburg, 620109, Russian Federation; ORCID iD 0000-0002-3616-2365.
Olga V. Kolmakova — Head of the Radiological Department, Novaya Bolnitsa LLC; 29, Zavodskaya str., Yekaterinburg, 620109, Russian Federation; ORCID iD 0000-0003-0092-4863.
Contact information: Olga V. Teplyakova, e-mail: oteplyakova69@gmail.com.
Financial Disclosure: no authors have a financial or property interest in any material or method mentioned.
There is no conflict of interest.
Received 03.04.2023.
Revised 24.04.2023.
Accepted 18.05.2023.
2. Gonzalez-Lopez L., Rocha-Muñoz A.D., Ponce-Guarneros M. et al. Anti-cyclic citrullinated peptide (anti-CCP) and anti-mutated citrullinated vimentin (anti-MCV) relation with extra-articular manifestations in rheumatoid arthritis. J Immunol Res. 2014;2014:536050. DOI: 10.1155/2014/536050.
3. Shimomura M., Ishihara S., Iwasaki M. Intractable pneumothorax due to rupture of subpleural rheumatoid nodules: a case report. Surg Case Rep. 2018;4(1):89. DOI: 10.1186/s40792-018-0502-8.
4. Shaw M., Collins B.F., Ho L.A. et al. Rheumatoid arthritis-associated lung disease. Eur Respir Rev. 2015;24(135):1–16. DOI: 10.1183/09059180.00008014.
5. Chirila R.M., Berianu F., Abril A. et al. Extra-articular involvement of rheumatoid arthritis in three seropositive patients in the absence of initial joint involvement. Immun Inflamm Dis. 2021;9(4):1613–1617. DOI: 10.1002/iid3.514.
6. Koslow M., Young J.R., Yi E.S. et al. Rheumatoid pulmonary nodules: clinical and imaging features compared with malignancy. Eur Radiol. 2019;29(4):1684–1692. DOI: 10.1007/s00330-018-5755-x.
7. Patatanian E., Thompson D.F. A review of methotrexate-induced accelerated nodulosis. Pharmacotherapy. 2002;22(9):1157–1162. DOI: 10.1592/phco.22.13.1157.33525.
8. Loverdos K., Fotiadis A., Kontogianni C. et al. Lung nodules: A comprehensive review on current approach and management. Ann Thorac Med. 2019;14(4):226–238. DOI: 10.4103/atm.ATM_110_19.
This work is licensed under a Creative Commons «Attribution» 4.0 License.
Распечатать